William R. Freeman

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

The Association Between Percent Disruption of the Photoreceptor Inner Segment–Outer Segment Junction and Visual Acuity in Diabetic Macular Edema

Anjali S. Maheshwary, Stephen F. Oster, R. M. S. Yuson et al. · American Journal of Ophthalmology · 2010 · 324 citations

Diabetic Retinopathy, Ocular Disease, Retina +7

A Prospective Study of the Ophthalmologic Findings in the Acquired Immune Deficiency Syndrome

William R. Freeman, Chester W. Lerner, Jonathan A. Mines et al. · American Journal of Ophthalmology · 1984 · 281 citations

Primary Immunodeficiency, Ocular Disease, Autoimmune Disease +10

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Lack of Reactivation of Cytomegalovirus (CMV) Retinitis after Stopping CMV Maintenance Therapy in AIDS Patients with Sustained Elevations in CD4 T Cells in Response to Highly Active Antiretroviral Therapy

Jonathan Macdonald, Francesca J. Torriani, Lawrence S. Morse et al. · The Journal of Infectious Diseases · 1998 · 238 citations